nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP2C9—Capecitabine—esophageal cancer	0.0719	0.665	CbGbCtD
Glipizide—CYP2C9—Cisplatin—esophageal cancer	0.0362	0.335	CbGbCtD
Glipizide—Blood in stool—Capecitabine—esophageal cancer	0.0279	0.0645	CcSEcCtD
Glipizide—Gastrointestinal tract irritation—Capecitabine—esophageal cancer	0.0128	0.0296	CcSEcCtD
Glipizide—Haematochezia—Capecitabine—esophageal cancer	0.0114	0.0263	CcSEcCtD
Glipizide—Inappropriate antidiuretic hormone secretion—Cisplatin—esophageal cancer	0.0107	0.0247	CcSEcCtD
Glipizide—Liver injury—Cisplatin—esophageal cancer	0.00738	0.0171	CcSEcCtD
Glipizide—Pain—Carboplatin—esophageal cancer	0.00646	0.0149	CcSEcCtD
Glipizide—Hepatocellular injury—Cisplatin—esophageal cancer	0.00621	0.0144	CcSEcCtD
Glipizide—Eruption—Methotrexate—esophageal cancer	0.00554	0.0128	CcSEcCtD
Glipizide—Polyuria—Cisplatin—esophageal cancer	0.00513	0.0119	CcSEcCtD
Glipizide—Liver disorder—Methotrexate—esophageal cancer	0.005	0.0116	CcSEcCtD
Glipizide—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00499	0.0115	CcSEcCtD
Glipizide—Gait disturbance—Capecitabine—esophageal cancer	0.00469	0.0108	CcSEcCtD
Glipizide—Chlorpropamide—PTGS1—esophageal cancer	0.0046	0.37	CrCbGaD
Glipizide—Hyponatraemia—Cisplatin—esophageal cancer	0.00452	0.0105	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00451	0.0104	CcSEcCtD
Glipizide—Urine output increased—Capecitabine—esophageal cancer	0.00414	0.00957	CcSEcCtD
Glipizide—Glyburide—ABCC2—esophageal cancer	0.00411	0.33	CrCbGaD
Glipizide—Abnormal vision—Capecitabine—esophageal cancer	0.00399	0.00923	CcSEcCtD
Glipizide—Hepatic function abnormal—Capecitabine—esophageal cancer	0.0038	0.00879	CcSEcCtD
Glipizide—Polyuria—Capecitabine—esophageal cancer	0.00378	0.00875	CcSEcCtD
Glipizide—Abdominal discomfort—Cisplatin—esophageal cancer	0.00373	0.00864	CcSEcCtD
Glipizide—Pancytopenia—Cisplatin—esophageal cancer	0.0037	0.00856	CcSEcCtD
Glipizide—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00368	0.00851	CcSEcCtD
Glipizide—Libido decreased—Capecitabine—esophageal cancer	0.00358	0.00829	CcSEcCtD
Glipizide—Thirst—Capecitabine—esophageal cancer	0.00349	0.00808	CcSEcCtD
Glipizide—Conjunctivitis—Cisplatin—esophageal cancer	0.00337	0.00781	CcSEcCtD
Glipizide—Hyponatraemia—Capecitabine—esophageal cancer	0.00333	0.00772	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00332	0.00769	CcSEcCtD
Glipizide—Diplopia—Capecitabine—esophageal cancer	0.00332	0.00769	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00329	0.00762	CcSEcCtD
Glipizide—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00328	0.0076	CcSEcCtD
Glipizide—Migraine—Capecitabine—esophageal cancer	0.00327	0.00756	CcSEcCtD
Glipizide—Aplastic anaemia—Methotrexate—esophageal cancer	0.0032	0.0074	CcSEcCtD
Glipizide—Urine output increased—Methotrexate—esophageal cancer	0.00308	0.00713	CcSEcCtD
Glipizide—Abdominal pain upper—Capecitabine—esophageal cancer	0.00303	0.00702	CcSEcCtD
Glipizide—Visual impairment—Cisplatin—esophageal cancer	0.003	0.00695	CcSEcCtD
Glipizide—Eye disorder—Cisplatin—esophageal cancer	0.00291	0.00674	CcSEcCtD
Glipizide—Flushing—Cisplatin—esophageal cancer	0.00289	0.00669	CcSEcCtD
Glipizide—Polyuria—Methotrexate—esophageal cancer	0.00282	0.00652	CcSEcCtD
Glipizide—Arrhythmia—Cisplatin—esophageal cancer	0.00278	0.00644	CcSEcCtD
Glipizide—Abdominal discomfort—Capecitabine—esophageal cancer	0.00275	0.00637	CcSEcCtD
Glipizide—Pancytopenia—Capecitabine—esophageal cancer	0.00273	0.00631	CcSEcCtD
Glipizide—Erythema—Cisplatin—esophageal cancer	0.00271	0.00628	CcSEcCtD
Glipizide—Dysuria—Capecitabine—esophageal cancer	0.00268	0.00621	CcSEcCtD
Glipizide—Flatulence—Cisplatin—esophageal cancer	0.00267	0.00619	CcSEcCtD
Glipizide—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00262	0.00606	CcSEcCtD
Glipizide—Visual disturbance—Methotrexate—esophageal cancer	0.00261	0.00604	CcSEcCtD
Glipizide—Muscle spasms—Cisplatin—esophageal cancer	0.00261	0.00604	CcSEcCtD
Glipizide—Vision blurred—Cisplatin—esophageal cancer	0.00256	0.00592	CcSEcCtD
Glipizide—Tremor—Cisplatin—esophageal cancer	0.00254	0.00588	CcSEcCtD
Glipizide—Ill-defined disorder—Cisplatin—esophageal cancer	0.00252	0.00583	CcSEcCtD
Glipizide—Jaundice—Capecitabine—esophageal cancer	0.00249	0.00577	CcSEcCtD
Glipizide—Conjunctivitis—Capecitabine—esophageal cancer	0.00249	0.00576	CcSEcCtD
Glipizide—Malaise—Cisplatin—esophageal cancer	0.00245	0.00566	CcSEcCtD
Glipizide—Leukopenia—Cisplatin—esophageal cancer	0.00243	0.00562	CcSEcCtD
Glipizide—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00242	0.0056	CcSEcCtD
Glipizide—Agranulocytosis—Capecitabine—esophageal cancer	0.00239	0.00553	CcSEcCtD
Glipizide—Myalgia—Cisplatin—esophageal cancer	0.00231	0.00535	CcSEcCtD
Glipizide—Rhinitis—Capecitabine—esophageal cancer	0.0023	0.00533	CcSEcCtD
Glipizide—Anxiety—Cisplatin—esophageal cancer	0.0023	0.00533	CcSEcCtD
Glipizide—Hepatitis—Capecitabine—esophageal cancer	0.0023	0.00532	CcSEcCtD
Glipizide—Hypoaesthesia—Capecitabine—esophageal cancer	0.00229	0.00529	CcSEcCtD
Glipizide—Discomfort—Cisplatin—esophageal cancer	0.00228	0.00528	CcSEcCtD
Glipizide—Pharyngitis—Capecitabine—esophageal cancer	0.00228	0.00528	CcSEcCtD
Glipizide—Chlorpropamide—ABCB1—esophageal cancer	0.00224	0.18	CrCbGaD
Glipizide—Oedema—Cisplatin—esophageal cancer	0.00221	0.00512	CcSEcCtD
Glipizide—Visual impairment—Capecitabine—esophageal cancer	0.00221	0.00512	CcSEcCtD
Glipizide—Thrombocytopenia—Cisplatin—esophageal cancer	0.00217	0.00502	CcSEcCtD
Glipizide—Eye disorder—Capecitabine—esophageal cancer	0.00215	0.00497	CcSEcCtD
Glipizide—Hyperhidrosis—Cisplatin—esophageal cancer	0.00214	0.00495	CcSEcCtD
Glipizide—Flushing—Capecitabine—esophageal cancer	0.00213	0.00493	CcSEcCtD
Glipizide—Anorexia—Cisplatin—esophageal cancer	0.00211	0.00488	CcSEcCtD
Glipizide—Chills—Capecitabine—esophageal cancer	0.00206	0.00477	CcSEcCtD
Glipizide—Arrhythmia—Capecitabine—esophageal cancer	0.00205	0.00475	CcSEcCtD
Glipizide—Abdominal discomfort—Methotrexate—esophageal cancer	0.00205	0.00474	CcSEcCtD
Glipizide—Pancytopenia—Methotrexate—esophageal cancer	0.00203	0.0047	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00202	0.00467	CcSEcCtD
Glipizide—Erythema—Capecitabine—esophageal cancer	0.002	0.00463	CcSEcCtD
Glipizide—Dysuria—Methotrexate—esophageal cancer	0.002	0.00462	CcSEcCtD
Glipizide—Paraesthesia—Cisplatin—esophageal cancer	0.00199	0.0046	CcSEcCtD
Glipizide—Dyspnoea—Cisplatin—esophageal cancer	0.00197	0.00457	CcSEcCtD
Glipizide—Flatulence—Capecitabine—esophageal cancer	0.00197	0.00456	CcSEcCtD
Glipizide—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00195	0.00451	CcSEcCtD
Glipizide—Decreased appetite—Cisplatin—esophageal cancer	0.00192	0.00445	CcSEcCtD
Glipizide—Muscle spasms—Capecitabine—esophageal cancer	0.00192	0.00445	CcSEcCtD
Glipizide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00191	0.00442	CcSEcCtD
Glipizide—Drowsiness—Methotrexate—esophageal cancer	0.00191	0.00441	CcSEcCtD
Glipizide—Pain—Cisplatin—esophageal cancer	0.00189	0.00438	CcSEcCtD
Glipizide—Vision blurred—Capecitabine—esophageal cancer	0.00188	0.00436	CcSEcCtD
Glipizide—Tremor—Capecitabine—esophageal cancer	0.00187	0.00434	CcSEcCtD
Glipizide—Ill-defined disorder—Capecitabine—esophageal cancer	0.00186	0.00429	CcSEcCtD
Glipizide—Conjunctivitis—Methotrexate—esophageal cancer	0.00185	0.00429	CcSEcCtD
Glipizide—Sweating—Methotrexate—esophageal cancer	0.00183	0.00423	CcSEcCtD
Glipizide—Feeling abnormal—Cisplatin—esophageal cancer	0.00182	0.00422	CcSEcCtD
Glipizide—Malaise—Capecitabine—esophageal cancer	0.0018	0.00417	CcSEcCtD
Glipizide—Hepatobiliary disease—Methotrexate—esophageal cancer	0.0018	0.00417	CcSEcCtD
Glipizide—Vertigo—Capecitabine—esophageal cancer	0.0018	0.00416	CcSEcCtD
Glipizide—Syncope—Capecitabine—esophageal cancer	0.00179	0.00415	CcSEcCtD
Glipizide—Leukopenia—Capecitabine—esophageal cancer	0.00179	0.00414	CcSEcCtD
Glipizide—Agranulocytosis—Methotrexate—esophageal cancer	0.00178	0.00411	CcSEcCtD
Glipizide—Loss of consciousness—Capecitabine—esophageal cancer	0.00176	0.00407	CcSEcCtD
Glipizide—Hypertension—Capecitabine—esophageal cancer	0.00173	0.004	CcSEcCtD
Glipizide—Hepatitis—Methotrexate—esophageal cancer	0.00171	0.00396	CcSEcCtD
Glipizide—Arthralgia—Capecitabine—esophageal cancer	0.0017	0.00394	CcSEcCtD
Glipizide—Myalgia—Capecitabine—esophageal cancer	0.0017	0.00394	CcSEcCtD
Glipizide—Pharyngitis—Methotrexate—esophageal cancer	0.0017	0.00393	CcSEcCtD
Glipizide—Anxiety—Capecitabine—esophageal cancer	0.0017	0.00393	CcSEcCtD
Glipizide—Discomfort—Capecitabine—esophageal cancer	0.00168	0.00389	CcSEcCtD
Glipizide—Visual impairment—Methotrexate—esophageal cancer	0.00165	0.00381	CcSEcCtD
Glipizide—Confusional state—Capecitabine—esophageal cancer	0.00165	0.00381	CcSEcCtD
Glipizide—Oedema—Capecitabine—esophageal cancer	0.00163	0.00378	CcSEcCtD
Glipizide—Hypersensitivity—Cisplatin—esophageal cancer	0.00163	0.00378	CcSEcCtD
Glipizide—Shock—Capecitabine—esophageal cancer	0.00161	0.00372	CcSEcCtD
Glipizide—Eye disorder—Methotrexate—esophageal cancer	0.0016	0.0037	CcSEcCtD
Glipizide—Thrombocytopenia—Capecitabine—esophageal cancer	0.0016	0.0037	CcSEcCtD
Glipizide—Asthenia—Cisplatin—esophageal cancer	0.00159	0.00368	CcSEcCtD
Glipizide—Hyperhidrosis—Capecitabine—esophageal cancer	0.00158	0.00365	CcSEcCtD
Glipizide—Anorexia—Capecitabine—esophageal cancer	0.00156	0.0036	CcSEcCtD
Glipizide—Chills—Methotrexate—esophageal cancer	0.00153	0.00355	CcSEcCtD
Glipizide—Diarrhoea—Cisplatin—esophageal cancer	0.00152	0.00351	CcSEcCtD
Glipizide—Glyburide—ABCB1—esophageal cancer	0.00151	0.121	CrCbGaD
Glipizide—Erythema—Methotrexate—esophageal cancer	0.00149	0.00345	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00149	0.00344	CcSEcCtD
Glipizide—Insomnia—Capecitabine—esophageal cancer	0.00148	0.00342	CcSEcCtD
Glipizide—Paraesthesia—Capecitabine—esophageal cancer	0.00147	0.00339	CcSEcCtD
Glipizide—Dyspnoea—Capecitabine—esophageal cancer	0.00146	0.00337	CcSEcCtD
Glipizide—Dyspepsia—Capecitabine—esophageal cancer	0.00144	0.00333	CcSEcCtD
Glipizide—Decreased appetite—Capecitabine—esophageal cancer	0.00142	0.00328	CcSEcCtD
Glipizide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00141	0.00326	CcSEcCtD
Glipizide—Vomiting—Cisplatin—esophageal cancer	0.00141	0.00326	CcSEcCtD
Glipizide—Vision blurred—Methotrexate—esophageal cancer	0.0014	0.00325	CcSEcCtD
Glipizide—Rash—Cisplatin—esophageal cancer	0.0014	0.00323	CcSEcCtD
Glipizide—Pain—Capecitabine—esophageal cancer	0.0014	0.00323	CcSEcCtD
Glipizide—Constipation—Capecitabine—esophageal cancer	0.0014	0.00323	CcSEcCtD
Glipizide—Dermatitis—Cisplatin—esophageal cancer	0.00139	0.00323	CcSEcCtD
Glipizide—Ill-defined disorder—Methotrexate—esophageal cancer	0.00138	0.0032	CcSEcCtD
Glipizide—Feeling abnormal—Capecitabine—esophageal cancer	0.00135	0.00311	CcSEcCtD
Glipizide—Malaise—Methotrexate—esophageal cancer	0.00134	0.00311	CcSEcCtD
Glipizide—Vertigo—Methotrexate—esophageal cancer	0.00134	0.0031	CcSEcCtD
Glipizide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00133	0.00309	CcSEcCtD
Glipizide—Leukopenia—Methotrexate—esophageal cancer	0.00133	0.00308	CcSEcCtD
Glipizide—Nausea—Cisplatin—esophageal cancer	0.00132	0.00304	CcSEcCtD
Glipizide—Urticaria—Capecitabine—esophageal cancer	0.0013	0.003	CcSEcCtD
Glipizide—Abdominal pain—Capecitabine—esophageal cancer	0.00129	0.00299	CcSEcCtD
Glipizide—Arthralgia—Methotrexate—esophageal cancer	0.00127	0.00293	CcSEcCtD
Glipizide—Myalgia—Methotrexate—esophageal cancer	0.00127	0.00293	CcSEcCtD
Glipizide—Discomfort—Methotrexate—esophageal cancer	0.00125	0.0029	CcSEcCtD
Glipizide—Confusional state—Methotrexate—esophageal cancer	0.00123	0.00284	CcSEcCtD
Glipizide—Hypersensitivity—Capecitabine—esophageal cancer	0.0012	0.00278	CcSEcCtD
Glipizide—Thrombocytopenia—Methotrexate—esophageal cancer	0.00119	0.00275	CcSEcCtD
Glipizide—Hyperhidrosis—Methotrexate—esophageal cancer	0.00117	0.00272	CcSEcCtD
Glipizide—Asthenia—Capecitabine—esophageal cancer	0.00117	0.00271	CcSEcCtD
Glipizide—Anorexia—Methotrexate—esophageal cancer	0.00116	0.00268	CcSEcCtD
Glipizide—Pruritus—Capecitabine—esophageal cancer	0.00115	0.00267	CcSEcCtD
Glipizide—Diarrhoea—Capecitabine—esophageal cancer	0.00112	0.00258	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00111	0.00256	CcSEcCtD
Glipizide—Insomnia—Methotrexate—esophageal cancer	0.0011	0.00254	CcSEcCtD
Glipizide—Paraesthesia—Methotrexate—esophageal cancer	0.00109	0.00253	CcSEcCtD
Glipizide—Dyspnoea—Methotrexate—esophageal cancer	0.00108	0.00251	CcSEcCtD
Glipizide—Somnolence—Methotrexate—esophageal cancer	0.00108	0.0025	CcSEcCtD
Glipizide—Dizziness—Capecitabine—esophageal cancer	0.00108	0.0025	CcSEcCtD
Glipizide—Dyspepsia—Methotrexate—esophageal cancer	0.00107	0.00248	CcSEcCtD
Glipizide—Decreased appetite—Methotrexate—esophageal cancer	0.00106	0.00244	CcSEcCtD
Glipizide—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00105	0.00243	CcSEcCtD
Glipizide—Pain—Methotrexate—esophageal cancer	0.00104	0.0024	CcSEcCtD
Glipizide—Vomiting—Capecitabine—esophageal cancer	0.00104	0.0024	CcSEcCtD
Glipizide—Rash—Capecitabine—esophageal cancer	0.00103	0.00238	CcSEcCtD
Glipizide—Dermatitis—Capecitabine—esophageal cancer	0.00103	0.00238	CcSEcCtD
Glipizide—Headache—Capecitabine—esophageal cancer	0.00102	0.00237	CcSEcCtD
Glipizide—Feeling abnormal—Methotrexate—esophageal cancer	0.001	0.00232	CcSEcCtD
Glipizide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000994	0.0023	CcSEcCtD
Glipizide—Nausea—Capecitabine—esophageal cancer	0.00097	0.00224	CcSEcCtD
Glipizide—Urticaria—Methotrexate—esophageal cancer	0.000965	0.00223	CcSEcCtD
Glipizide—Abdominal pain—Methotrexate—esophageal cancer	0.000961	0.00222	CcSEcCtD
Glipizide—Hypersensitivity—Methotrexate—esophageal cancer	0.000895	0.00207	CcSEcCtD
Glipizide—Asthenia—Methotrexate—esophageal cancer	0.000872	0.00202	CcSEcCtD
Glipizide—Pruritus—Methotrexate—esophageal cancer	0.00086	0.00199	CcSEcCtD
Glipizide—Diarrhoea—Methotrexate—esophageal cancer	0.000831	0.00192	CcSEcCtD
Glipizide—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.000816	0.00182	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.000805	0.0018	CbGpPWpGaD
Glipizide—Dizziness—Methotrexate—esophageal cancer	0.000804	0.00186	CcSEcCtD
Glipizide—KCNJ11—Metabolism—SLC10A2—esophageal cancer	0.000796	0.00178	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CA1—esophageal cancer	0.000796	0.00178	CbGpPWpGaD
Glipizide—PPARG—SREBP signalling—PIK3CA—esophageal cancer	0.000788	0.00176	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000778	0.00174	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000777	0.00174	CbGpPWpGaD
Glipizide—Vomiting—Methotrexate—esophageal cancer	0.000773	0.00179	CcSEcCtD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000772	0.00173	CbGpPWpGaD
Glipizide—Rash—Methotrexate—esophageal cancer	0.000766	0.00177	CcSEcCtD
Glipizide—Dermatitis—Methotrexate—esophageal cancer	0.000765	0.00177	CcSEcCtD
Glipizide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000762	0.0017	CbGpPWpGaD
Glipizide—Headache—Methotrexate—esophageal cancer	0.000761	0.00176	CcSEcCtD
Glipizide—ABCC8—Metabolism—CA2—esophageal cancer	0.000751	0.00168	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ACTB—esophageal cancer	0.000748	0.00167	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—NOS2—esophageal cancer	0.000741	0.00166	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000736	0.00165	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CTNNA1—esophageal cancer	0.000735	0.00164	CbGpPWpGaD
Glipizide—PPARG—PPARA activates gene expression—EP300—esophageal cancer	0.000734	0.00164	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CA2—esophageal cancer	0.000728	0.00163	CbGpPWpGaD
Glipizide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—esophageal cancer	0.000727	0.00162	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000726	0.00162	CbGpPWpGaD
Glipizide—Nausea—Methotrexate—esophageal cancer	0.000722	0.00167	CcSEcCtD
Glipizide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—esophageal cancer	0.000718	0.00161	CbGpPWpGaD
Glipizide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000717	0.0016	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.00071	0.00159	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PLCE1—esophageal cancer	0.000698	0.00156	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ADH7—esophageal cancer	0.000698	0.00156	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SMG6—esophageal cancer	0.000692	0.00155	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC52A3—esophageal cancer	0.000692	0.00155	CbGpPWpGaD
Glipizide—PPARG—Metabolism—BLVRB—esophageal cancer	0.000692	0.00155	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000684	0.00153	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PLCE1—esophageal cancer	0.000677	0.00151	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ADH7—esophageal cancer	0.000677	0.00151	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—CDKN1A—esophageal cancer	0.000675	0.00151	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	0.000665	0.00149	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000633	0.00141	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000626	0.0014	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000626	0.0014	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000623	0.00139	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000618	0.00138	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000613	0.00137	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ADH1B—esophageal cancer	0.000612	0.00137	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000611	0.00137	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000599	0.00134	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ADH1B—esophageal cancer	0.000593	0.00133	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.000593	0.00133	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000589	0.00132	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CA1—esophageal cancer	0.000588	0.00131	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC10A2—esophageal cancer	0.000588	0.00131	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—TYMP—esophageal cancer	0.000585	0.00131	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000579	0.00129	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000575	0.00128	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000571	0.00128	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP26A1—esophageal cancer	0.000569	0.00127	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—TYMP—esophageal cancer	0.000567	0.00127	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALOX15—esophageal cancer	0.000554	0.00124	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP26A1—esophageal cancer	0.000552	0.00123	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000538	0.0012	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CA2—esophageal cancer	0.000538	0.0012	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALOX15—esophageal cancer	0.000538	0.0012	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000531	0.00119	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTO1—esophageal cancer	0.000529	0.00118	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—TPI1—esophageal cancer	0.000529	0.00118	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000526	0.00118	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NR1I2—esophageal cancer	0.000524	0.00117	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000515	0.00115	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTO1—esophageal cancer	0.000513	0.00115	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—TPI1—esophageal cancer	0.000513	0.00115	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALDOB—esophageal cancer	0.000507	0.00113	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.000504	0.00113	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ABL1—esophageal cancer	0.000501	0.00112	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PLCE1—esophageal cancer	0.0005	0.00112	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADH7—esophageal cancer	0.0005	0.00112	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000497	0.00111	CbGpPWpGaD
Glipizide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	0.000495	0.00111	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000494	0.00111	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALDOB—esophageal cancer	0.000492	0.0011	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GAPDH—esophageal cancer	0.000488	0.00109	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000486	0.00109	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—SMAD4—esophageal cancer	0.000485	0.00108	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CRABP1—esophageal cancer	0.000484	0.00108	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000474	0.00106	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GAPDH—esophageal cancer	0.000473	0.00106	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CRABP1—esophageal cancer	0.000469	0.00105	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000468	0.00105	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GNG7—esophageal cancer	0.00046	0.00103	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—EP300—esophageal cancer	0.000453	0.00101	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HIST1H2BM—esophageal cancer	0.00045	0.00101	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GNG7—esophageal cancer	0.000446	0.000997	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000439	0.000981	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADH1B—esophageal cancer	0.000439	0.00098	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALDH2—esophageal cancer	0.000431	0.000964	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TYMP—esophageal cancer	0.000419	0.000937	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALDH2—esophageal cancer	0.000418	0.000935	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000417	0.000933	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000413	0.000922	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTT1—esophageal cancer	0.00041	0.000917	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP26A1—esophageal cancer	0.000408	0.000911	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP2A6—esophageal cancer	0.000405	0.000906	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTT1—esophageal cancer	0.000398	0.000889	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALOX15—esophageal cancer	0.000397	0.000888	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP2A6—esophageal cancer	0.000393	0.000879	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000391	0.000874	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ENO1—esophageal cancer	0.000384	0.000859	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS1—esophageal cancer	0.000384	0.000859	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000384	0.000858	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.00038	0.000849	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KDR—esophageal cancer	0.000379	0.000848	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTO1—esophageal cancer	0.000379	0.000847	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TPI1—esophageal cancer	0.000379	0.000847	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PSME2—esophageal cancer	0.000379	0.000847	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PSME1—esophageal cancer	0.000379	0.000847	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS1—esophageal cancer	0.000373	0.000833	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ENO1—esophageal cancer	0.000373	0.000833	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MET—esophageal cancer	0.000371	0.00083	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PSME1—esophageal cancer	0.000367	0.000821	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PSME2—esophageal cancer	0.000367	0.000821	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALDOB—esophageal cancer	0.000363	0.000812	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NOTCH1—esophageal cancer	0.000357	0.000799	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GAPDH—esophageal cancer	0.00035	0.000782	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PSME2—esophageal cancer	0.000349	0.00078	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PSME1—esophageal cancer	0.000349	0.00078	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CRABP1—esophageal cancer	0.000347	0.000775	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000344	0.00077	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000333	0.000743	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GNG7—esophageal cancer	0.00033	0.000737	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NOTCH3—esophageal cancer	0.000329	0.000736	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000329	0.000734	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000328	0.000733	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP1B1—esophageal cancer	0.000327	0.00073	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—esophageal cancer	0.000324	0.000725	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CREBBP—esophageal cancer	0.000324	0.000724	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP1B1—esophageal cancer	0.000317	0.000708	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000313	0.000699	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALDH2—esophageal cancer	0.000309	0.000691	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000308	0.000689	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP19A1—esophageal cancer	0.000307	0.000687	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP19A1—esophageal cancer	0.000298	0.000666	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NOTCH2—esophageal cancer	0.000295	0.00066	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTT1—esophageal cancer	0.000294	0.000657	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP2A6—esophageal cancer	0.000291	0.000649	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000289	0.000647	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000287	0.000641	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—HMOX1—esophageal cancer	0.00028	0.000627	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ENO1—esophageal cancer	0.000275	0.000616	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS1—esophageal cancer	0.000275	0.000616	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—HMOX1—esophageal cancer	0.000272	0.000608	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PSME1—esophageal cancer	0.000271	0.000607	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PSME2—esophageal cancer	0.000271	0.000607	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ERBB2—esophageal cancer	0.000271	0.000607	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ABCB1—esophageal cancer	0.000269	0.000602	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ABCB1—esophageal cancer	0.000261	0.000583	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000255	0.00057	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000255	0.00057	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SMAD4—esophageal cancer	0.000248	0.000554	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000237	0.00053	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP1B1—esophageal cancer	0.000234	0.000523	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000228	0.000509	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EP300—esophageal cancer	0.000221	0.000493	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP19A1—esophageal cancer	0.00022	0.000492	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000217	0.000484	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA1—esophageal cancer	0.000217	0.000484	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—MYC—esophageal cancer	0.000204	0.000457	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HMOX1—esophageal cancer	0.000201	0.000449	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA2—esophageal cancer	0.000198	0.000443	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000197	0.000441	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000194	0.000433	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCB1—esophageal cancer	0.000193	0.000431	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EGFR—esophageal cancer	0.000188	0.000421	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.000184	0.000412	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADH7—esophageal cancer	0.000184	0.000412	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NOTCH1—esophageal cancer	0.000183	0.000409	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000182	0.000407	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CREBBP—esophageal cancer	0.00018	0.000402	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CREBBP—esophageal cancer	0.000174	0.00039	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000168	0.000376	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000168	0.000376	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CREBBP—esophageal cancer	0.000166	0.000371	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.000162	0.000361	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NOS3—esophageal cancer	0.000161	0.00036	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NOS3—esophageal cancer	0.000156	0.000349	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TYMP—esophageal cancer	0.000154	0.000345	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP26A1—esophageal cancer	0.00015	0.000336	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—esophageal cancer	0.000147	0.000329	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALOX15—esophageal cancer	0.000146	0.000327	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000146	0.000326	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000143	0.000319	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA1—esophageal cancer	0.000143	0.000319	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—esophageal cancer	0.000143	0.000319	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TPI1—esophageal cancer	0.00014	0.000312	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTO1—esophageal cancer	0.00014	0.000312	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDOB—esophageal cancer	0.000134	0.000299	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA2—esophageal cancer	0.000131	0.000292	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CREBBP—esophageal cancer	0.000129	0.000288	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GAPDH—esophageal cancer	0.000129	0.000288	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CRABP1—esophageal cancer	0.000128	0.000285	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—EP300—esophageal cancer	0.000122	0.000274	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000121	0.000272	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000121	0.000272	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GNG7—esophageal cancer	0.000121	0.000271	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—EP300—esophageal cancer	0.000119	0.000266	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NOS3—esophageal cancer	0.000115	0.000258	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDH2—esophageal cancer	0.000114	0.000254	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTT1—esophageal cancer	0.000108	0.000242	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2A6—esophageal cancer	0.000107	0.000239	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000107	0.000238	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000107	0.000238	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—esophageal cancer	0.000106	0.000236	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TYMP—esophageal cancer	0.000102	0.000228	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ENO1—esophageal cancer	0.000101	0.000227	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS1—esophageal cancer	0.000101	0.000227	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PSME1—esophageal cancer	9.99e-05	0.000223	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PSME2—esophageal cancer	9.99e-05	0.000223	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	9.9e-05	0.000221	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MYC—esophageal cancer	9.84e-05	0.00022	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.65e-05	0.000216	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TPI1—esophageal cancer	9.21e-05	0.000206	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTO1—esophageal cancer	9.21e-05	0.000206	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CA—esophageal cancer	9.06e-05	0.000203	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.83e-05	0.000197	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CA—esophageal cancer	8.79e-05	0.000196	CbGpPWpGaD
Glipizide—PPARG—Metabolism—EP300—esophageal cancer	8.78e-05	0.000196	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.73e-05	0.000195	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP1B1—esophageal cancer	8.62e-05	0.000193	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.5e-05	0.00019	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CRABP1—esophageal cancer	8.42e-05	0.000188	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP19A1—esophageal cancer	8.11e-05	0.000181	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GNG7—esophageal cancer	8.01e-05	0.000179	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.5e-05	0.000168	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMOX1—esophageal cancer	7.4e-05	0.000165	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.26e-05	0.000162	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.14e-05	0.00016	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCB1—esophageal cancer	7.1e-05	0.000159	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	7.06e-05	0.000158	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ENO1—esophageal cancer	6.69e-05	0.00015	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.69e-05	0.00015	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PSME2—esophageal cancer	6.59e-05	0.000147	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PSME1—esophageal cancer	6.59e-05	0.000147	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CA—esophageal cancer	6.49e-05	0.000145	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.69e-05	0.000127	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.37e-05	0.00012	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.35e-05	0.00012	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.88e-05	0.000109	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CREBBP—esophageal cancer	4.75e-05	0.000106	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.68e-05	0.000105	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NOS3—esophageal cancer	4.25e-05	9.5e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.89e-05	8.69e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—EP300—esophageal cancer	3.23e-05	7.23e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.13e-05	7e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NOS3—esophageal cancer	2.8e-05	6.27e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.56e-05	5.73e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.39e-05	5.35e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—EP300—esophageal cancer	2.13e-05	4.77e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.58e-05	3.53e-05	CbGpPWpGaD
